September 1st, 2015.

WntRx Pharmaceuticals was accepted to the Harvard innovation Lab's Fall 2015-16 Venture Incubation Program.

February 29, 2016
WntRx is one of four startups in the 2016 MassCONNECT program, sponsored by MassBio.

October 1st, 2013.

WntRx obtained its patent license from the Dana-Farber Cancer Institute.

July 1st, 2014.

WntRx Pharmaceuticals moved to LabCentral, located in an historic, MIT-owned building at 700 Main Street, Cambridge. 

July 1st, 2015. 

WntRx Pharmaceuticals has received seed round financing of 1M from TEEC Angel Fund, Venture Leader Group.

May 1st, 2014. 

WntRx Pharmaceuticals has closed its angel round 500K financing.